Cargando…

Chinese Patent Medicine as Adjuvant for Mild-to-Moderate Active Ulcerative Colitis: A Network Meta-Analysis of Randomized Controlled Trials

OBJECTIVE: To evaluate the effectiveness and safety of Chinese patent medicine for mild-to-moderate active ulcerative colitis (UC) using network meta-analysis (NMA). METHODS: We systematically searched PubMed, Cochrane library, Embase, Sino-Med, China National Knowledge Infrastructure (CNKI), Wanfan...

Descripción completa

Detalles Bibliográficos
Autores principales:	Sun, Yu-Xin, Yang, Guo-Yan, Karamacoska, Diana, Wang, Xiao, Li, Yuan-Xi, Hou, Wen-Bin, Zheng, You-You, Liu, Jian-Ping, Liu, Zhao-Lan
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Hindawi 2021
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8413025/ https://www.ncbi.nlm.nih.gov/pubmed/34484384 http://dx.doi.org/10.1155/2021/1075886

Ejemplares similares

An evidence mapping of systematic reviews and meta-analysis on traditional Chinese medicine for ulcerative colitis
por: Sun, Yu-Xin, et al.
Publicado: (2021)

Health-Related Quality of Life in Chinese Patients with Mild and Moderately Active Ulcerative Colitis
por: Zheng, Kai, et al.
Publicado: (2015)

Traditional Chinese medicine for mild-to-moderate ulcerative colitis: Protocol for a network meta-analysis of randomized controlled trials
por: Shen, Zhaofeng, et al.
Publicado: (2019)

Acute moderate to severe ulcerative colitis treated by traditional Chinese medicine: A case report
por: Wu, Bin
Publicado: (2022)

Key Strategies to Optimize Outcomes in Mild-to-Moderate Ulcerative Colitis
por: Solitano, Virginia, et al.
Publicado: (2020)

Mild to moderate ulcerative colitis: Call me by my name
por: Rodríguez‐Lago, Iago, et al.
Publicado: (2022)

Clinical evaluation of traditional Chinese medicine on mild active ulcerative colitis: A multi-center, randomized, double-blind, controlled trial
por: Kou, Fu-Shun, et al.
Publicado: (2020)

Once-daily MMX mesalamine for the treatment of mild-to-moderate ulcerative colitis
por: Kedia, Prashant, et al.
Publicado: (2007)

Network meta-analysis of Chinese patent medicine adjuvant treatment of poststroke depression
por: Yu, Ying, et al.
Publicado: (2020)

Mesalazine granules promote disease clearance in patients with mild‐to‐moderate ulcerative colitis
por: Kruis, Wolfgang, et al.
Publicado: (2023)

Five-Flavor Sophora flavescens Enteric-Coated Capsules for Ulcerative Colitis: A Systematic Review and Meta-Analysis of Randomized Clinical Trials
por: Hou, Wen Bin, et al.
Publicado: (2022)

Modelling the benefits of an optimised treatment strategy for 5-ASA in mild-to-moderate ulcerative colitis
por: Louis, Edouard, et al.
Publicado: (2022)

Definition of mild to moderate ulcerative colitis in clinical trials: A systematic literature review
por: Caron, Bénédicte, et al.
Publicado: (2022)

Fecal microbiota transplantation versus glucocorticoids for the induction of remission in mild to moderate ulcerative colitis
por: Huang, Chunlan, et al.
Publicado: (2022)

Mild-to-Moderate Ulcerative Colitis: Your Role in Patient Compliance and Health Care Costs
por: Tindall, William N., et al.
Publicado: (2007)

Treatment of Patients with Mild to Moderate Ulcerative Colitis: A Middle East Expert Consensus
por: Awadhi, Sameer Al, et al.
Publicado: (2023)

Medication Formulation Preference of Mild and Moderate Ulcerative Colitis Patients: a European Survey
por: Hébuterne, Xavier, et al.
Publicado: (2023)

International Consensus on Definition of Mild-to-Moderate Ulcerative Colitis Disease Activity in Adult Patients
por: Caron, Bénédicte, et al.
Publicado: (2023)

The Efficacy of Flupentixol-Melitracen in the Adjuvant Therapy of Ulcerative Colitis in the Chinese Population: A Meta-Analysis
por: Zhou, Xiaoqian, et al.
Publicado: (2019)

Gut microbiota contributes to the distinction between two traditional Chinese medicine syndromes of ulcerative colitis
por: Zhang, Ya-Li, et al.
Publicado: (2019)

Budesonide MMX for the Induction of Remission of Mild to Moderate Ulcerative Colitis: A Pooled Safety Analysis
por: Lichtenstein, Gary R., et al.
Publicado: (2015)

Vitamin D Status and Its Relation to Inflammatory Markers in Patients with Mild to Moderate Ulcerative Colitis
por: Sharifi, Amrollah, et al.
Publicado: (2018)

Vitamin D Increases CTLA-4 Gene Expression in Patients with Mild to Moderate Ulcerative Colitis
por: Sharifi, Amrollah, et al.
Publicado: (2019)

The impact of clinical experience on decision-making regarding the treatment and management of mild-to-moderate ulcerative colitis
por: Cheon, Jae Hee, et al.
Publicado: (2023)

Application of network pharmacology in the study of mechanism of Chinese medicine in the treatment of ulcerative colitis: A review
por: Zheng, Shihao, et al.
Publicado: (2022)

Chinese herbal medicines in the treatment of ulcerative colitis: a review
por: Zhang, Xuan, et al.
Publicado: (2022)

Ulcerative colitis in an adult patient mimicking Henoch–Schönlein purpura: A case report
por: Lu, Bin, et al.
Publicado: (2018)

Herbal Medicine in the Treatment of Ulcerative Colitis
por: Ke, Fei, et al.
Publicado: (2012)

Combined Diosmectite and Mesalazine Treatment for Mild-to-Moderate Ulcerative Colitis: A Randomized, Placebo-Controlled Study
por: Jiang, Xue-Liang, et al.
Publicado: (2015)

High- and Low-Dose Oral Delayed-Release Mesalamine in Children With Mild-to-Moderately Active Ulcerative Colitis
por: Winter, Harland S., et al.
Publicado: (2014)

Is once daily multimatrix mesalazine therapy effective regardless of the dose in patients with mild to moderate ulcerative colitis?
por: Jeon, Seong Ran
Publicado: (2018)

Prevalence and screening for anaemia in mild to moderate Crohn's disease and ulcerative colitis in the United States, 2010–2014
por: Akhuemonkhan, Eboselume, et al.
Publicado: (2017)

The Efficacy and Safety of Mesalamine and Probiotics in Mild-to-Moderate Ulcerative Colitis: A Systematic Review and Meta-Analysis
por: Tian, Chunying, et al.
Publicado: (2020)

Ulcerative Colitis-Symptom Questionnaire: Valid for Use in Adults with Moderately to Severely Active Ulcerative Colitis
por: Panes, Julian, et al.
Publicado: (2023)

Development of a Traditional Chinese Medicine Syndrome-Specific Scale for Ulcerative Colitis: The Large Intestine Dampness-Heat Syndrome Questionnaire
por: Chen, Xin-lin, et al.
Publicado: (2018)

Budesonide Multimatrix Is Efficacious for Mesalamine-refractory, Mild to Moderate Ulcerative Colitis: A Randomised, Placebo-controlled Trial
por: Rubin, David T., et al.
Publicado: (2017)

Factor-XIII activity in patients with mild to moderate ulcerative colitis and active bleeding: a prospective observational study
por: Bernerth, Karsten, et al.
Publicado: (2018)

A potential therapeutic target in traditional Chinese medicine for ulcerative colitis: Macrophage polarization
por: Yang, Zhihua, et al.
Publicado: (2022)

Traditional Chinese Medicine Alleviates Ulcerative Colitis via Modulating Gut Microbiota
por: Feng, Wan, et al.
Publicado: (2022)

Adjuvant treatment of coronary heart disease angina pectoris with Chinese patent medicine: A prospective clinical cohort study
por: Liu, Yijia, et al.
Publicado: (2019)

Cannot write session to /tmp/vufind_sessions/sess_cr2a5g04d3a4s5cs015nbkuhat